🕵️ VTV Therapeutics Inc. ($VTVT)
SEC insider & ownership activity, last 12 months · CIK 1641489 · every row links its SEC filing
Insiders were quiet over the last 12 months – no open-market buys or sells. Samsara Biocapital, L.P. trimmed 6.5% → 6.2%; Samsara Biocapital GP, LLC trimmed 6.5% → 6.2%. No red-flag 8-Ks in the window.
Insider flow
0 buyers, $0 (0 lots) · 0 sellers, $0 (0 lots)
No open-market insider transactions in the last 12 months.
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Srinivas Akkaraju | 9.9% | 13D | Dec 8, 2025 | filing ↗ | |
| Trails EDGE Capital Partners, LP | 9.9% | 13G | Sep 8, 2025 | filing ↗ | |
| Trails EDGE Biotechnology Master Fund, LP | 9.9% | 13G | Sep 8, 2025 | filing ↗ | |
| Ortav Yehudai | 9.9% | 13G | Sep 8, 2025 | filing ↗ | |
| Raymond Debbane | 9.4% | 13G | Nov 12, 2025 | filing ↗ | |
| Invus Public Equities, L.P. | 8.4% | 13G | Nov 12, 2025 | filing ↗ | |
| Invus Public Equities Advisors, LLC | 8.4% | 13G | Nov 12, 2025 | filing ↗ | |
| Invus Global Management, LLC | 8.4% | 13G | Nov 12, 2025 | filing ↗ | |
| Siren, L.L.C. | 8.4% | 13G | Nov 12, 2025 | filing ↗ | |
| Samsara Biocapital, L.P. | 6.2% | 13D | Dec 8, 2025 | filing ↗ | |
| Samsara Biocapital GP, LLC | 6.2% | 13D | Dec 8, 2025 | filing ↗ | |
| Millennium Management LLC | 5.7% | 13G | Apr 16, 2026 | filing ↗ | |
| Millennium Group Management LLC | 5.7% | 13G | Apr 16, 2026 | filing ↗ | |
| Israel A. Englander | 5.7% | 13G | Apr 16, 2026 | filing ↗ | |
| Integrated CORE Strategies (US) LLC | 5.0% | 13G | Apr 16, 2026 | filing ↗ |
Planned insider sales (Form 144)
No sale notices filed in the last 12 months.
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Shareholder vote (5.07) | Jun 26, 2026 | filing ↗ |
| Earnings (2.02) | May 13, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 13, 2026 | filing ↗ |
| Other events (8.01) | May 13, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 13, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Mar 10, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 10, 2026 | filing ↗ |
| Earnings (2.02) | Mar 10, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 10, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Feb 26, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 26, 2026 | filing ↗ |
| Material agreement (1.01) | Jan 30, 2026 | filing ↗ |
| Charter/bylaw changes (5.03) | Dec 19, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Dec 19, 2025 | filing ↗ |
| Earnings (2.02) | Nov 6, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 6, 2025 | filing ↗ |
| Reg FD disclosure (7.01) | Sep 10, 2025 | filing ↗ |
| Material agreement (1.01) | Aug 29, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 29, 2025 | filing ↗ |
| Earnings (2.02) | Aug 12, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 12, 2025 | filing ↗ |